<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00811811</url>
  </required_header>
  <id_info>
    <org_study_id>04-516-BE</org_study_id>
    <nct_id>NCT00811811</nct_id>
  </id_info>
  <brief_title>Behavioral Neurocardiac Training and Hypertension</brief_title>
  <official_title>Behavioral Neurocardiac Training With Biofeedback Augments Vagal-Heart Rate Modulation and Baroreflex Sensitivity Among Patients With Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial will examine whether behavioral neurocardiac training with
      heart rate variability biofeedback (BNT) augments reduction in ambulatory daytime and 24-hour
      SBP, DBP and PP, in comparison to an active control intervention (AC, autogenic relaxation
      training), among subjects diagnosed with hypertension, and following adjustment for
      medications. In addition, the independent association between the BNT and AC interventions on
      vagal-heart rate modulation and baroreflex sensitivity will be evaluated during a
      standardized assessment protocol of mental stress testing. This study extends a previous
      trial conducted at the UHN, in which we reported that the biofeedback intervention
      independently augments vagal-heart rate modulation, while reducing symptoms of stress and
      depressed mood, among subjects diagnosed with cardiovascular disease. Exploratory features of
      this trial will examine the association between ambulatory blood pressure, vagal-heart rate
      modulation, baroreflex sensitivity, and markers of inflammatory activity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ambulatory daytime and 24-hour systolic blood pressure, diastolic blood pressure, and pulse pressure.</measure>
    <time_frame>Baseline and Post-treatment (following 6 treatment sessions scheduled over an 8-week interval)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>RR interval, vagal-heart rate modulation (high frequency power in RR interval variability [0.15-0.40 Hz/ms2]) and baroreflex sensitivity</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavioral neurocardiac training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autogenic relaxation training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral neurocardiac training</intervention_name>
    <description>6 training sessions scheduled over 8 weeks</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Autogenic relaxation training</intervention_name>
    <description>6 training sessions scheduled over 8 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  35 to 64 years of age

          -  diagnosis of Grade 1 or 2 hypertension (140-159 mmHg or 160-180 mmHg SBP; or 90-99 or
             100-110 mmHg DBP, respectively).

          -  among subjects not prescribed medication, hypertension confirmed by ambulatory BP
             monitoring: mean 24-hour SBP &gt; 130 mmHg or DBP &gt; 80 mmHg.

          -  subjects prescribed antihypertensive pharmacotherapy are required to have a treatment
             regimen that was unchanged for at least 4 months prior to enrollment.

        Exclusion criteria:

          -  diagnosis of cardiovascular disease, clinically significant arrhythmia, sleep
             disorder, psychiatric illness (eg. psychosis), alcohol/drug dependence within the
             previous year, or an inability to comprehend English or French
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert P Nolan, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2008</study_first_submitted>
  <study_first_submitted_qc>December 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2008</study_first_posted>
  <last_update_submitted>December 18, 2008</last_update_submitted>
  <last_update_submitted_qc>December 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Robert P. Nolan/Director Behavioural Cardiology Research Unit</name_title>
    <organization>University Health Network</organization>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Biofeedback</keyword>
  <keyword>Relaxation training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

